Cancer deaths are down in the U.S., but the disease is taking hold in younger populations, likely fueled by obesity, alcohol ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

A phase 3 trial of Daiichi Sankyo and Merck & Co.’s HER3-directed antibody-drug conjugate (ADC) has hit its primary endpoint, ...

The Rybrevant-Lazcluze combo lowered the risk of death by 23% compared with Tagrisso in an updated analysis of the phase 3 ...

A new study reports that by 2050, global cancer cases in men are expected to increase by 84%. Cancer deaths for men are ...

Treatment of non-small cell lung cancer (NSCLC) depends on the stage you're in and can include chemotherapy, surgery, ...

Pulmonary nodules smaller than two centimetres can be cured if detected early As part of European Lung Cancer Week, Dr Joseba ...

Lung cancer is tied to tobacco smoking in the public consciousness, but a significant proportion of cases are driven by ...

We quantified the proportion of diagnoses of pulmonary fibrosis (PF) among 25 136 people with lung cancer and 250 583 matched ...

More people who have never touched a cigarette are getting lung cancer, but there are ways to prevent it, according to a doctor.

Ifinatamab deruxtecan, a novel antibody-drug conjugate, returned promising response rates at both dose levels evaluated among ...